ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
Identifieur interne : 000033 ( PubMed/Corpus ); précédent : 000032; suivant : 000034ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
Auteurs : Augustine Ankomah ; John Kuumuori Ganle ; Margaret Yaa Lartey ; Awewura Kwara ; Priscilla Awo Nortey ; Michael Perry Kweku Okyerefo ; Amos Kankponang LaarSource :
- BMC infectious diseases [ 1471-2334 ] ; 2016.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Anti-HIV Agents (therapeutic use), Cross-Sectional Studies, Female, Ghana (epidemiology), HIV Infections (drug therapy), HIV Infections (epidemiology), HIV Infections (psychology), Health Personnel, Health Services Accessibility, Humans, Interviews as Topic, Male, Middle Aged, Motivation, Social Stigma, Young Adult.
- MESH :
- chemical , therapeutic use : Anti-HIV Agents.
- drug therapy : HIV Infections.
- epidemiology : Ghana, HIV Infections.
- psychology : HIV Infections.
- Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Health Personnel, Health Services Accessibility, Humans, Interviews as Topic, Male, Middle Aged, Motivation, Social Stigma, Young Adult.
Abstract
Timely and enduring access to antiretroviral therapy (ART) by HIV-infected individuals has been shown to substantially reduce HIV transmission risk, HIV-related morbidity and mortality. However, there is evidence that in addition to limited supply of antiretrovirals (ARVs) and linkage to ART in many low-income countries, HIV+ persons often encounter barriers in accessing ART-related services even in contexts where these services are freely available. In Ghana, limited research evidence exists regarding the barriers HIV+ persons already linked to ART face. This paper explores ART access-related barriers that HIV+ persons linked to care in southern Ghana face.
DOI: 10.1186/s12879-016-2075-0
PubMed: 27927183
Links to Exploration step
pubmed:27927183Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.</title><author><name sortKey="Ankomah, Augustine" sort="Ankomah, Augustine" uniqKey="Ankomah A" first="Augustine" last="Ankomah">Augustine Ankomah</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Ganle, John Kuumuori" sort="Ganle, John Kuumuori" uniqKey="Ganle J" first="John Kuumuori" last="Ganle">John Kuumuori Ganle</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Lartey, Margaret Yaa" sort="Lartey, Margaret Yaa" uniqKey="Lartey M" first="Margaret Yaa" last="Lartey">Margaret Yaa Lartey</name><affiliation><nlm:affiliation>Department of Medicine, University of Ghana School of Medicine & Dentistry, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Kwara, Awewura" sort="Kwara, Awewura" uniqKey="Kwara A" first="Awewura" last="Kwara">Awewura Kwara</name><affiliation><nlm:affiliation>Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nortey, Priscilla Awo" sort="Nortey, Priscilla Awo" uniqKey="Nortey P" first="Priscilla Awo" last="Nortey">Priscilla Awo Nortey</name><affiliation><nlm:affiliation>Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Okyerefo, Michael Perry Kweku" sort="Okyerefo, Michael Perry Kweku" uniqKey="Okyerefo M" first="Michael Perry Kweku" last="Okyerefo">Michael Perry Kweku Okyerefo</name><affiliation><nlm:affiliation>Department of Sociology, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Laar, Amos Kankponang" sort="Laar, Amos Kankponang" uniqKey="Laar A" first="Amos Kankponang" last="Laar">Amos Kankponang Laar</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana. alaar@ug.edu.gh.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27927183</idno><idno type="pmid">27927183</idno><idno type="doi">10.1186/s12879-016-2075-0</idno><idno type="wicri:Area/PubMed/Corpus">000033</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000033</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.</title><author><name sortKey="Ankomah, Augustine" sort="Ankomah, Augustine" uniqKey="Ankomah A" first="Augustine" last="Ankomah">Augustine Ankomah</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Ganle, John Kuumuori" sort="Ganle, John Kuumuori" uniqKey="Ganle J" first="John Kuumuori" last="Ganle">John Kuumuori Ganle</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Lartey, Margaret Yaa" sort="Lartey, Margaret Yaa" uniqKey="Lartey M" first="Margaret Yaa" last="Lartey">Margaret Yaa Lartey</name><affiliation><nlm:affiliation>Department of Medicine, University of Ghana School of Medicine & Dentistry, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Kwara, Awewura" sort="Kwara, Awewura" uniqKey="Kwara A" first="Awewura" last="Kwara">Awewura Kwara</name><affiliation><nlm:affiliation>Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Nortey, Priscilla Awo" sort="Nortey, Priscilla Awo" uniqKey="Nortey P" first="Priscilla Awo" last="Nortey">Priscilla Awo Nortey</name><affiliation><nlm:affiliation>Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Okyerefo, Michael Perry Kweku" sort="Okyerefo, Michael Perry Kweku" uniqKey="Okyerefo M" first="Michael Perry Kweku" last="Okyerefo">Michael Perry Kweku Okyerefo</name><affiliation><nlm:affiliation>Department of Sociology, University of Ghana, Legon, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Laar, Amos Kankponang" sort="Laar, Amos Kankponang" uniqKey="Laar A" first="Amos Kankponang" last="Laar">Amos Kankponang Laar</name><affiliation><nlm:affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana. alaar@ug.edu.gh.</nlm:affiliation></affiliation></author></analytic><series><title level="j">BMC infectious diseases</title><idno type="eISSN">1471-2334</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Anti-HIV Agents (therapeutic use)</term><term>Cross-Sectional Studies</term><term>Female</term><term>Ghana (epidemiology)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (epidemiology)</term><term>HIV Infections (psychology)</term><term>Health Personnel</term><term>Health Services Accessibility</term><term>Humans</term><term>Interviews as Topic</term><term>Male</term><term>Middle Aged</term><term>Motivation</term><term>Social Stigma</term><term>Young Adult</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Ghana</term><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Cross-Sectional Studies</term><term>Female</term><term>Health Personnel</term><term>Health Services Accessibility</term><term>Humans</term><term>Interviews as Topic</term><term>Male</term><term>Middle Aged</term><term>Motivation</term><term>Social Stigma</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Timely and enduring access to antiretroviral therapy (ART) by HIV-infected individuals has been shown to substantially reduce HIV transmission risk, HIV-related morbidity and mortality. However, there is evidence that in addition to limited supply of antiretrovirals (ARVs) and linkage to ART in many low-income countries, HIV+ persons often encounter barriers in accessing ART-related services even in contexts where these services are freely available. In Ghana, limited research evidence exists regarding the barriers HIV+ persons already linked to ART face. This paper explores ART access-related barriers that HIV+ persons linked to care in southern Ghana face.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27927183</PMID><DateCreated><Year>2016</Year><Month>12</Month><Day>08</Day></DateCreated><DateCompleted><Year>2017</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2017</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Dec</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.</ArticleTitle><Pagination><MedlinePgn>738</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Timely and enduring access to antiretroviral therapy (ART) by HIV-infected individuals has been shown to substantially reduce HIV transmission risk, HIV-related morbidity and mortality. However, there is evidence that in addition to limited supply of antiretrovirals (ARVs) and linkage to ART in many low-income countries, HIV+ persons often encounter barriers in accessing ART-related services even in contexts where these services are freely available. In Ghana, limited research evidence exists regarding the barriers HIV+ persons already linked to ART face. This paper explores ART access-related barriers that HIV+ persons linked to care in southern Ghana face.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A mixed method study design, involving a cross-sectional survey and qualitative in-depth interviews, was conducted to collect data from four healthcare providers and a total of 540 adult HIV+ persons receiving ART at four treatment centres in Ghana. We used univariate analysis to generate descriptive tabulations for key variables from the survey. Data from qualitative in-depth interviews were thematically analysed. Results from the survey and in-depth interviews were brought together to illuminate the challenges of the HIV+ persons.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All (100%) the HIV+ persons interviewed were ARV-exposed and linked to ART. Reasons for taking ARVs ranged from beliefs that they will suppress the HIV virus, desire to maintain good health and prolong life, and desire to prevent infection in unborn children, desire both to avoid death and to become good therapeutic citizens (abide by doctors' advice). Despite this, more than half of the study participants (63.3%) reported seven major factors as barriers hindering access to ART. These were high financial costs associated with accessing and receiving ART (26%), delays associated with receiving care from treatment centres (24%), shortage of drugs and other commodities (23%), stigma (8.8%), fear of side effects of taking ARVs (7.9%), job insecurity arising from regular leave of absence to receive ART (5.3%), and long distance to treatment centres (4.9%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results in this study suggest that efforts to provide and scale-up ART to all HIV+ persons must be accompanied by interventions that address structural and individual level access barriers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ankomah</LastName><ForeName>Augustine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganle</LastName><ForeName>John Kuumuori</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lartey</LastName><ForeName>Margaret Yaa</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ghana School of Medicine & Dentistry, University of Ghana, Legon, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwara</LastName><ForeName>Awewura</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nortey</LastName><ForeName>Priscilla Awo</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Disease Control, School of Public Health, University of Ghana, Legon, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okyerefo</LastName><ForeName>Michael Perry Kweku</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Sociology, University of Ghana, Legon, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laar</LastName><ForeName>Amos Kankponang</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Population, Family and Reproductive Health, School of Public Health, University of Ghana, Legon, Accra, Ghana. alaar@ug.edu.gh.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019380">Anti-HIV Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Ghana Med J. 2009 Dec;43(4):142-3</RefSource><PMID Version="1">21326992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2010 Sep;22(9):1146-52</RefSource><PMID Version="1">20824567</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2000 Jun;30 Suppl 2:S96-116</RefSource><PMID Version="1">10860894</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2007 Dec 1;196 Suppl 3:S474-81</RefSource><PMID Version="1">18181697</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2001 Apr 14;357(9263):1149-53</RefSource><PMID Version="1">11323041</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S109-12</RefSource><PMID Version="1">21857292</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2015 Jan 28;29(3):361-71</RefSource><PMID Version="1">25686684</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2010 Jun;15 Suppl 1:70-5</RefSource><PMID Version="1">20586963</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2007 Jan;19(1):28-33</RefSource><PMID Version="1">17129855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Psychol. 2004 Mar;23(2):207-18</RefSource><PMID Version="1">15008666</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Global Health. 2011 May 15;7:13</RefSource><PMID Version="1">21575149</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Gen Intern Med. 2009 Oct;24(10):1101-8</RefSource><PMID Version="1">19653047</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care. 2003 Apr;41(4):512-21</RefSource><PMID Version="1">12665715</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2014 Sep;19(9):1015-28</RefSource><PMID Version="1">24976370</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2003 Oct 11;362(9391):1234-7</RefSource><PMID Version="1">14568749</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):e104-9</RefSource><PMID Version="1">24525471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2008 Jul;13(7):870-9</RefSource><PMID Version="1">18373510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Mycobacteriol. 2014 Dec;3(4):268-75</RefSource><PMID Version="1">26786626</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ghana Med J. 2009 Dec;43(4):144-9</RefSource><PMID Version="1">21326993</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2005 Aug 25;353(8):752</RefSource><PMID Version="1">16120853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Glob Health Sci Pract. 2015 Jan 27;3(1):1-11</RefSource><PMID Version="1">25745115</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care. 2006 Nov;44(11):990-7</RefSource><PMID Version="1">17063130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2003 Oct 17;17(15):2227-36</RefSource><PMID Version="1">14523280</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Equity Health. 2014 Nov 15;13:109</RefSource><PMID Version="1">25398271</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Care. 2007 May;19(5):658-65</RefSource><PMID Version="1">17505927</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>SAHARA J. 2012;9(2):74-87</RefSource><PMID Version="1">23237042</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019380" MajorTopicYN="N">Anti-HIV Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N">Ghana</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="N">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057545" MajorTopicYN="N">Social Stigma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIDS</Keyword><Keyword MajorTopicYN="N">Access</Keyword><Keyword MajorTopicYN="N">Antiretroviral therapy</Keyword><Keyword MajorTopicYN="N">Antiretrovirals</Keyword><Keyword MajorTopicYN="N">Barriers</Keyword><Keyword MajorTopicYN="N">Ghana</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">PLH</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27927183</ArticleId><ArticleId IdType="doi">10.1186/s12879-016-2075-0</ArticleId><ArticleId IdType="pii">10.1186/s12879-016-2075-0</ArticleId><ArticleId IdType="pmc">PMC5142337</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000033 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000033 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27927183
|texte= ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27927183" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |